Bico
Bico, formerly known as Bico Group, is a pioneering company headquartered in Sweden (SE) that operates at the forefront of the biotechnology industry. Founded in 2016, Bico has rapidly established itself as a leader in bioprinting and biofabrication, with a focus on advancing healthcare and sustainable materials. The company’s innovative core products include advanced bioprinters and bioinks, which enable the creation of complex biological structures for research and therapeutic applications. Bico's unique approach combines cutting-edge technology with a commitment to sustainability, positioning it as a key player in the global market. With significant operational regions across Europe and North America, Bico has achieved notable milestones, including strategic partnerships and collaborations that enhance its market presence. As a result, Bico continues to drive innovation and shape the future of biotechnology.
DitchCarbon Score
How does Bico's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bico's score of 34 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bico's reported carbon emissions
In 2023, Bico reported significant carbon emissions, with total Scope 3 emissions amounting to approximately 4,000,150 kg CO2e. This figure includes 3,417,000 kg CO2e from business travel, 54,150 kg CO2e from waste generated in operations, and 868,000 kg CO2e from downstream transportation and distribution. In 2022, Bico's emissions were recorded at about 2,149,000 kg CO2e for Scope 3 and 1,406,000 kg CO2e for combined Scope 1 and 2 emissions. The previous year, 2021, saw Scope 3 emissions at approximately 2,529,000 kg CO2e, alongside 284,000 kg CO2e for Scope 1 and 2. Bico has committed to achieving net-zero emissions, as indicated by their status with the Science Based Targets initiative (SBTi). They are currently classified as "Committed" to near-term targets, although specific reduction targets have not been detailed. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector and is headquartered in Sweden. Bico's emissions data is not cascaded from any parent organization, ensuring that their reported figures are independently sourced.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | - | - | - |
| Scope 3 | 2,529,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bico is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
